urinary incontinence
First Wave acquires Sanofiās Alzheimerās drug for GI disorders, retains buyback option
Anika Sharma
First Wave BioPharma has seized an opportunity from Sanofi to revive a long-dormant molecule, capeserod, by paying an upfront sum ...
Astellas Faces Setback in the US Patent Trial for Myrbetriq
SG Tylor
Source – Astellas An important patent that Astellas has on the urinary incontinence medicine Myrbetriq has been declared invalid by ...
